| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.844 | 17.615 | 17.205 | 15.632 | 13.878 | 13.720 | 11.971 | 17.531 | 13.397 | 11.476 |
| Total Income - EUR | 15.844 | 17.615 | 17.205 | 15.632 | 13.878 | 13.720 | 11.971 | 17.531 | 13.397 | 11.476 |
| Total Expenses - EUR | 15.745 | 18.614 | 19.184 | 18.511 | 17.443 | 17.420 | 15.926 | 20.176 | 18.423 | 15.102 |
| Gross Profit/Loss - EUR | 99 | -999 | -1.979 | -2.879 | -3.565 | -3.700 | -3.956 | -2.645 | -5.026 | -3.626 |
| Net Profit/Loss - EUR | -377 | -1.351 | -2.151 | -3.035 | -3.703 | -3.837 | -4.076 | -2.820 | -5.160 | -3.792 |
| Employees | 0 | 2 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
Check the financial reports for the company - Diflu Exim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 11.221 | 8.889 | 5.001 | 2.674 | 3.751 | 3.178 | 2.581 | 1.435 | 2.019 | 4.328 |
| Inventories | 11.024 | 8.100 | 4.644 | 2.245 | 3.679 | 3.097 | 2.468 | 1.240 | 1.930 | 3.228 |
| Receivables | 58 | 58 | 57 | 56 | 55 | 54 | 52 | 0 | 6 | 134 |
| Cash | 139 | 731 | 300 | 373 | 17 | 28 | 61 | 195 | 83 | 966 |
| Shareholders Funds | -18.984 | -20.141 | -21.952 | -24.584 | -27.811 | -31.121 | -34.506 | -37.433 | -42.480 | -46.034 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 30.205 | 29.030 | 26.953 | 27.258 | 31.562 | 34.299 | 37.088 | 38.868 | 44.499 | 50.362 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Diflu Exim S.r.l.